CERT 250117 12.50P (CERT250117P12500) Stock Options, News & Quotes

US OptionsDetailed Quotes

CERT250117P12500

Watchlist

0.80
-2.00-71.43%

15min DelayClose Jan 17 16:00 ET

0.80High0.80Low

Intraday

5D
Daily

News

Certara's Solid FY24 Performance and Cautious Outlook Lead to Hold Rating Despite Increased Price Target
TipRanksJan 17 01:06 ET · Ratings
BofA Securities Maintains Certara(CERT.US) With Buy Rating, Maintains Target Price $15
Moomoo NewsJan 16 10:33 ET · Ratings
BofA Securities Maintains Certara(CERT.US) With Buy Rating, Announces Target Price $15
Moomoo NewsJan 15 20:33 ET · Ratings
Certara's Strong Financial Performance and Strategic AI Positioning Drive Positive Outlook
TipRanksJan 15 20:20 ET
Certara Up Over 10%, on Pace for Largest Percent Increase Since November 2023 -- Data Talk
Dow JonesJan 15 11:21 ET
Certara Shares Are Trading Higher After the Company Provided Q4 and FY24 Revenue and Adjusted EBITDA Guidance.
BenzingaJan 15 10:07 ET

Comments

Moomoo AI

Mar 21, 2024 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet (FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin (APP.US)$
...